Familial Recurrence Rate of Autism Spectrum Disorder 20.2 Percent

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 17, 2024 -- The familial recurrence rate of autism spectrum disorder (ASD) is 20.2 percent, which has not changed significantly from previous estimates, according to a study published online July 16 in Pediatrics.

Sally Ozonoff, Ph.D., from the University of California Davis Health in Sacramento, and colleagues collated data across 18 sites of the Baby Siblings Research Consortium to update estimates of familial ASD recurrence. A total of 1,605 infants with an older sibling with autism were followed from early in life to age 3 years, at which point they were classified as ASD or non-ASD.

The researchers found that 20.2 percent of siblings developed ASD, which is not significantly different from the previously reported rate (18.7 percent). Significant predictors of familial recurrence included male infant sex and more than one older affected sibling. Recurrence rates were also influenced by proband sex, with the likelihood of developing ASD significantly higher for siblings of female probands than siblings of male probands. Associations were also seen for race and maternal education with recurrence in families.

"The current study reinforces the importance of developmental surveillance and screening for younger siblings of autistic children, particularly those who are male, have an affected female sibling, or have multiple affected siblings," the authors write.

Several authors disclosed ties to the pharmaceutical and publishing industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-18 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords